STTCOMP MEB FA LONG
Medibio Ltd
Market cap - around $17m
Medibio is a medical technology company developing tests to assist in the diagnosis of depression, other mental health disorders and chronic stress. I liked today's announcement about the global agreement with Compass Group for ilumen which is a corporate wellness product. However, the main catalyst for me is the FDA approval for MEB-001 which is a device to assist in the diagnosis of depression. It is due around November 30 according to the AGM presentation announcement. Bit of a binary event - approval could see the share price fly whereas denial would see a big hit to the share price (obviously).
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 23 Nov
Short Term Trading Week Starting: 23 Nov, page-29
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)